Press Releases QuidelOrtho Corporation

Stocks

QDEL

US2197981051

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 21:00:00 12/06/2026 BST			5-day change	1st Jan Change
14.13 ^USD	+0.28%		-7.65%	-50.53%

05-07	UBS Adjusts Price Target on QuidelOrtho to $12 From $17, Maintains Neutral Rating	MT
05-07	Jefferies Downgrades QuidelOrtho to Hold From Buy, Adjusts Price Target to $12.50 From $35	MT

Press Releases

05-20	QuidelOrtho to Participate in Upcoming June 2026 Investor Conferences	PR
05-06	QuidelOrtho : Quarterly Report for Quarter Ending March 29, 2026 (Form 10-Q)	PU
05-05	QuidelOrtho: Q1 Earnings Snapshot	AQ
05-05	QuidelOrtho Reports First Quarter 2026 Financial Results	PR
04-23	QuidelOrtho : Understanding and Addressing Syphilis Trends - and What's Being Missed	PU
04-20	QuidelOrtho Corporation Completes Acquisition of LEX Diagnostics	PR
04-15	QuidelOrtho Announces Preliminary Revenue for the First Quarter 2026 and Provides Update on Full-Year 2026 Guidance	PR
03-24	Nathaniel Sisitsky Joins QuidelOrtho as Chief Legal Officer	PR
02-19	QuidelOrtho : Annual Report for Fiscal Year Ending December 28, 2025 (Form 10-K)	PU
02-18	QuidelOrtho to Present at the 47th Annual Raymond James Institutional Investor Conference	PR
02-11	QuidelOrtho: Q4 Earnings Snapshot	AQ
02-11	QuidelOrtho Reports Fourth Quarter and Full-Year 2025 Financial Results	PR
02-03	QuidelOrtho Receives Excellence Services Label in EMEA and Two Stevie® Awards	PR
01-21	QuidelOrtho to Report Fourth Quarter and Full-Year 2025 Financial Results	PR
11-24	QuidelOrtho To Participate In Upcoming Investor Conferences	PR
11-20	The Power of Prevention: Detecting Diabetes Before It Strikes	PU
11-05	QuidelOrtho: Q3 Earnings Snapshot	AQ
11-05	QuidelOrtho Reports Third Quarter 2025 Financial Results	PR
11-03	QuidelOrtho Receives FDA 510(k) Clearance for VITROS™ Immunodiagnostic Products hs Troponin I Assay	PR
22/10/25	QuidelOrtho to Report Third Quarter 2025 Financial Results	PR
23/09/25	QuidelOrtho Announces Availability of QUICKVUE Influenza + SARS Test for Professional Use	AQ
22/09/25	QuidelOrtho Announces Availability of QUICKVUE™ Influenza + SARS Test for Professional Use	PR
28/08/25	QuidelOrtho to Participate in the Baird 2025 Global Healthcare Conference	PR
21/08/25	QuidelOrtho Completes Debt Refinancing	PR
19/08/25	QuidelOrtho Welcomes Erich Wolff as Executive Vice President, Strategy & Corporate Development	PR